Previous studies involving genetically engineered mouse models and human cell lines have emphasized the phenomenon of transcriptional heterogeneity in SCLC and pointed to discordant expression of key lineage factors (e.g. ASCL1, NEUROD1, REST)31,38. The gene discussed is ASCL1; the disease is small cell lung carcinoma.